<DOC>
	<DOCNO>NCT02048410</DOCNO>
	<brief_summary>Probiotics propose treatment dyslipidemia . investigator aim evaluate efficacy , tolerability safety new symbiotic formulation contain combination probiotic prebiotics amine treatment child affect familial hypercholesterolemia ( FH ) .</brief_summary>
	<brief_title>Efficacy New Symbiotic Formulation Children With Familial Hypercholesterolemia</brief_title>
	<detailed_description>FH subject , age 6-12 year , consecutively observed Tertiary Center Pediatric Nutrition randomly allocate two group intervention 6 month : active group , receive low saturate fat diet plus symbiotic ( 2.5×109cfu , bid ) 6 month ; control group , receive low saturate fat diet alone . All child receive write indication low saturate fat diet . The plasmatic lipid profile assess peripheral blood sample T0 T1 .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<criteria>age ≥ 6 ≤ 12 year . Diagnosis hypercholesterolemia ( LDL cholesterol &gt; 140 mg / dl ) Each patient must show resistance dietary therapy last least 612 month . Age &lt; 6 &gt; 12 year . Patients undergoing drug treatment hypercholesterolemia . Any medical condition may interfere participation study Participation clinical trial still progress . Taking pre / probiotic 7 day 6 month prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>